Current Edition

biosims

Organon shares jump as Merck’s new women’s health spinoff posts strong start for biosims, infertility drugs

It’s been a mere two months since Merck’s women’s health spinoff Organon set off to chart its own path as an independent company. That hasn’t …

Continue Reading →